Recall Ledger

Glycopyrrolate Oral Solution recall (NOVADOZ PHARMACEUTICALS LLC)

DrugClass IIIOngoing

Summary: NOVADOZ PHARMACEUTICALS LLC is recalling Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72. Reason: Failed Impurities/Degradation Specifications.

What is being recalled

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

Why

Failed Impurities/Degradation Specifications

How serious is it

Class III is the least serious level: using or being exposed to this product is not likely to cause health problems, but it breaks FDA rules.

Where it was sold

US Nationwide.

How to tell if yours is affected

Lot # CB2505159A, CB2505160A, Exp Date: 04/2027; Lot # CB2505161A, Exp Date: 05/2027

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0300-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass III
StatusOngoing
Recall startedDecember 15, 2025
ReportedFebruary 4, 2026
CompanyNOVADOZ PHARMACEUTICALS LLC
Company locationPiscataway, NJ, United States
Initiated byVoluntary: Firm initiated
QuantityN/A

More recalls from NOVADOZ PHARMACEUTICALS LLC · all drug recalls · recalls from December 2025

Official FDA record